An agonist human ICOS monoclonal antibody that induces T cell activation and inhibits proliferation of a myeloma cell line

Hybridoma and Hybridomics

Volumn 23, Issue 3, 2004, Pages 176-182

  Deng, Zhong Bin ^a   Zhu, Wei ^b   Lu, Chang Ming ^a   Shi, Qin ^b   Ju, Song Gunag ^a   Ma, Hong Bing ^a   Xu, Yin ^a   Zhang, Xue Guang ^a,c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Key Laboratory of Radiation Medicine and Protection of Jiangsu Province   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE COSTIMULATOR MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; EPITOPES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MULTIPLE MYELOMA; T-LYMPHOCYTES;

ANIMALIA;

EID: 3042831301     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/1536859041224299     Document Type: Article

References (33)

1. Mueller DL, Jenkins MK, and Schwartz RH: Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
2. Lenschow DJ, Walunas TL, and Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
3. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, and Kroczek RA: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999;397:263-266.
4. Tamatani T, Tezuka K, and Hanzawa-Higuchi N: AILIM/ICOS: A novel lymphocyte adhesion molecule. Int Immunol 2000;12:51-55.
5. Mages HW, Hutloff A, Heuck C, Buchner K, Himmelbauer H, Oliveri F and Kroczek RA. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol 2000;30:1040-1047.
6. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, et al: T-cell Costimulation through B7RP-1 and ICOS. Nature 1999;402:827-832.
7. Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Buchner K, Ludewig B, Ochs HD, Mages HW, and Kroczek RA: Induction, binding specificity and function of human ICOS. Eur J Immunol 2000;30:3707-3717.
8. + T cells. J Immunol 2000;165:5035-5040.
9. Brodie D, Collins AV, Iaboni A, Fennelly JA, Sparks LM, Xu XN, van der Merwe PA, and Davis SJ: LICOS, a primordial costimulatory ligand? Curr Biol 2000;10:333-336.
10. Ling V, Wu PW, Finnerty HF, Bean KM, Spaulding V, Fouser LA, Leonard JP, Hunter SE, Zollner R, Thomas JL, et al: Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000;164:1653-1657.
11. Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, and Clark EA: Characterization of human inducible costimulator ligand expression and function. J Immunol 2000;164:4689-4696.
12. Yoshinaga SK, Zhang M, Pistillo J, Horan T, Khare SD, Miner K, Sonnenberg M, Boone T, Brankow D, Dai T, et al: Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 2000;12:1439-1447.
13. Liang L, Porter EM, and Sha WC: Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J Exp Med 2002;196:97-108.
14. Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos JC, and Coyle AJ: ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001;2:597-604.
15. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, et al: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000;13:95-105.
16. Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, Gallimore A, Gutierrez-Ramos JC, and Bachmann MF: Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000;192:53-61
17. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, and Chen L: Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000;96:2808-2813.
18. Swallow MM, Wallin JJ, and Sha WC: B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-α. Immunity 1999;11:423-432.
19. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, and Sharpe AH: ICOS is critical for CD40-mediated antibody class switching. Nature 2001;409:102-105.
20. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A, Boucher LM, Bouchard D, Chan VS, Duncan G, et al: ICOS is essential for effective T-helper-cell responses. Nature 2001;409:105-109.
21. Zhang XG, Olive D, Devos J, Rebouissou C, Ghiotto-Ragueneau M, Ferlin M, and Klein B: Malignant plasma cell lines express a functional CD28 molecule. Leukemia 1998;12:610-618.
22. Deng ZB, Lu CM, Shen LQ, Zhu W, Xu Y, Fan BS, and Zhang XG. Effects of Human ICOS cDNA transfected cells on the production of T-lymphocytes dependent antibodies. Shanghai J Immunol 2003;23:314-317.
23. Zhou ZH, Wang JF, Wang YD, Qiu YH, Pan JZ, Xie W, Jiang LY, Klein B, and Zhang XG: An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of myeloma cell line. Hybridoma 1999;18:471-477.
24. Deng ZB, Lu CM, Huang WD, Shen LQ, Zhu W, Ma HB, Fan PS, and Zhang XG: Expression of recombinant human ICOS and in vitro characterization of its bioactivity on B lymphocytes. Acta Biochim Biophys Sin 2003;35:601-605.
25. Tezuka K, Tsuji T, Hirano D, Tamatani T, Sakamaki K, Kobayashi Y, and Kamada M: Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family. Biochem Biophys Res Commun 2000;276:335-345.
26. Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, and Flavell RA: ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001;409:97-101.
27. Banchereau J, and Rousset F: Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 1992;52:125-262.
28. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, and Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-1032.
29. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, and Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989;73:517-526.
30. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, Boiron JM, Bataille R, and Klein B: Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994;83:3654-3663.
31. Klein B, Zhang XG, Lu ZY, and Bataille R: Interleukin-6 in human multiple myeloma. Blood 1995;85:863-872.
32. De Vos J, Couderc G, Tarte K, Jourdan M, Requirand G, Delteil MC, Rossi JF, Mechti N, and Klein B: Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood 2001;98:771-780.
33. Wang YD, De vos J, Jourdan M, Coudere G, Lu ZY, Rossi JF, and Klein B: Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Oncogene 2002;21:2584-2592.